Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
William Tembo: Understanding Stroke Through Landmark Clinical Trials
William Tembo/LinkedIn
Mar 13, 2026, 20:50

William Tembo: Understanding Stroke Through Landmark Clinical Trials

William Tembo, Stroke Research Fellow, Acute Care Research Coordinator at University of Minnesota, shared on LinkedIn:

”Trial Thursday

Someone recently told me, ‘Stroke is stroke. Every stroke is treated the same way.’

It is an understandable thought. Many stroke patients receive similar core treatments such as antiplatelet therapy, blood pressure control, statins, and risk factor management.

From the outside, it can look like the approach is always the same.

But in reality, stroke is not one disease.

Stroke can result from several different mechanisms including large artery atherosclerosis, cardioembolism, small vessel disease, arterial dissection, and other less common causes.

Each mechanism carries different risks and may require different treatment strategies.

  • Some patients need antiplatelets.
  • Others require anticoagulation.
  • Some benefit from carotid intervention.
  • Others from endovascular thrombectomy.

These differences are not theoretical. They come from evidence generated by major stroke trials that have shaped modern stroke care.

So I am starting a series called Trial Thursday.

Each week I will break down one important stroke trial and discuss

  • the clinical question
  • the study design
  • the key results
  • and how it changed practice

Because in stroke care, the mechanism matters and the evidence matters.

Stay tuned.”

William Tembo: Understanding Stroke Through Landmark Clinical Trials

Stay updated with Hemostasis Today.

clinical trials Health Hematology Hemostasis Hemostasis News Hemostasis Today Medicine stroke thrombosis William Tembo
NewsFeed